Peer Review reports
From: Pyoderma gangrenosum in a patient with multiple sclerosis under natalizumab treatment: a case report
| Original Submission | ||
|---|---|---|
| 14 Oct 2024 | Submitted | Original manuscript |
| 17 Oct 2024 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 2 | ||
| 17 Oct 2024 | Submitted | Manuscript version 2 |
| 18 Oct 2024 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 3 | ||
| 18 Oct 2024 | Submitted | Manuscript version 3 |
| 2 Dec 2024 | Reviewed | Reviewer Report |
| 7 Jan 2025 | Reviewed | Reviewer Report |
| 27 Jan 2025 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 4 | ||
| 27 Jan 2025 | Submitted | Manuscript version 4 |
| 1 Feb 2025 | Reviewed | Reviewer Report |
| 18 Feb 2025 | Reviewed | Reviewer Report |
| 26 Feb 2025 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 5 | ||
| 26 Feb 2025 | Submitted | Manuscript version 5 |
| 15 Mar 2025 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 6 | ||
| 15 Mar 2025 | Submitted | Manuscript version 6 |
| 18 Mar 2025 | Author responded | Author comments - Mohammadali Sahraian |
| Resubmission - Version 7 | ||
| 18 Mar 2025 | Submitted | Manuscript version 7 |
| Publishing | ||
| 20 Mar 2025 | Editorially accepted | |
| 2 Apr 2025 | Article published | 10.1186/s12883-025-04146-z |
You can find further information about peer review here.